Aspira Women’s Health Inc. Deferred Tax Assets, Valuation Allowance
Aspira Women’s Health Inc. (AWHL) had Deferred Tax Assets, Valuation Allowance of $34.31 million as of 2025-12-31, per its 10-K filed 2026-04-01.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Components of Deferred Tax Assets › Deferred Tax Assets, Net › Deferred Tax Assets, Net of Valuation Allowance
us-gaap:DeferredTaxAssetsValuationAllowance · last filed 2026-04-01
- 2025-12-31: Deferred Tax Assets, Valuation Allowance $34.31M.
- 2024-12-31: Deferred Tax Assets, Valuation Allowance $60.10M; Deferred Tax Assets, Valuation Allowance as first filed $60.05M.
- 2023-12-31: Deferred Tax Assets, Valuation Allowance $57.17M.
- 2022-12-31: Deferred Tax Assets, Valuation Allowance $49.68M; Deferred Tax Assets, Valuation Allowance as first filed $49.45M.
| Period end | Deferred Tax Assets, Valuation Allowance | Deferred Tax Assets, Valuation Allowance as first filed |
|---|---|---|
| 2025-12-31 | $34.31M 10-K · filed 2026-04-01 | |
| 2024-12-31 | $60.10M 10-K · filed 2026-04-01 | $60.05M 10-K · filed 2025-03-27 |
| 2023-12-31 | $57.17M 10-K · filed 2025-03-27 | |
| 2022-12-31 | $49.68M 10-K · filed 2024-04-01 | $49.45M 10-K · filed 2023-03-30 |
| 2021-12-31 | $41.89M 10-K/A · filed 2023-10-26 | |
| 2020-12-31 | $35.20M 10-K · filed 2022-03-31 | |
| 2019-12-31 | $31.87M 10-K · filed 2021-03-31 | $34.50M 10-K · filed 2020-04-07 |
| 2018-12-31 | $25.43M 10-K · filed 2020-04-07 | |
| 2017-12-31 | $23.32M 10-K · filed 2019-03-28 | |
| 2016-12-31 | $31.09M 10-K · filed 2018-03-13 | |
| 2015-12-31 | $74.27M 10-K · filed 2017-03-31 | |
| 2014-12-31 | $67.43M 10-K · filed 2016-03-30 | |
| 2013-12-31 | $64.35M 10-K · filed 2015-03-31 | |
| 2012-12-31 | $57.30M 10-K · filed 2014-03-31 | |
| 2011-12-31 | $55.21M 10-K · filed 2013-03-01 |